How to Use Ask the Advocate
Expert cardiometabolic education. Clearer answers. Better questions.
Ask the Advocate is CardioAdvocate's educational chatbot designed to help individuals better understand cardiometabolic health — including heart disease, cholesterol, lipids, diabetes, obesity, blood pressure, imaging, and prevention.
This tool exists to bridge a common gap in healthcare: patients are often given complex information, test results, and recommendations — but not always the context needed to understand what it means, why it matters, or what questions to ask next. Ask the Advocate is built to help with exactly that.
Tips for Getting the Most Out of It
💬
Ask in Plain Language
Type your question the way you'd ask a friend who happens to be a cardiologist. No medical jargon needed.
🔍
Be Specific
Instead of "tell me about cholesterol," try "what's the difference between LDL particle number and LDL cholesterol?" The more focused, the better the answer.
📚
Follow the Trail
The chatbot draws from CardioAdvocate's articles, glossary, and library. Ask follow-up questions — each answer can lead you deeper into the topic.
⚡
Prepare for Your Visit
Use it before your next doctor's appointment. Ask about your test results, a new diagnosis, or a medication — so you walk in with better questions.
What Ask the Advocate Can Help With
Ask the Advocate is designed to support education and understanding, not diagnosis or treatment. It can help you:
✓
Understand medical terms, lab values, and imaging findings
✓
Learn how cardiometabolic risk is assessed and what the numbers mean
✓
Explore evidence-based prevention concepts for heart disease, diabetes, and related conditions
✓
Interpret the language of guidelines and medical literature
✓
Prepare more informed questions for your healthcare team
✓
Explore topics like cholesterol, ApoB, Lp(a), coronary calcium, metabolic syndrome, insulin resistance, hypertension, and more
What Ask the Advocate Is Not
Ask the Advocate does not provide medical advice, diagnoses, treatment recommendations, or personalized care plans. Use of this tool does not create a physician–patient relationship.
Healthcare decisions should always be made in partnership with a licensed healthcare professional who knows your individual medical history.
How This Tool Is Different
Ask the Advocate is being developed with a deliberate philosophy:
Education over automation
— We help you understand why something matters, not just what the result says.
Expert-curated content
— Responses draw from cardiologist-reviewed articles, not generic search results.
Nuance over soundbites
— Real cardiometabolic health is complex. We don't oversimplify.
Always evolving
— As CardioAdvocate grows, Ask the Advocate will incorporate refined sources, better explanations, and more nuanced educational support. Your feedback and curiosity help shape its future.
Frequently Asked Questions
Try asking the chatbot above — or browse these common questions to get started.
▶
How do I interpret my cholesterol test results?
A standard lipid panel reports total cholesterol, LDL-C, HDL-C, and triglycerides — but those numbers only tell part of the story. What often matters more is
what's driving the LDL number: how many LDL particles you have (LDL-P or ApoB), whether your triglyceride-to-HDL ratio suggests insulin resistance, and whether advanced markers like Lp(a) have been checked. CardioAdvocate's
Atherogenic Triad and
Understanding Your Test Results pages walk through what each value means and which questions to bring to your clinician.
▶
What are the most effective lifestyle changes to reduce heart disease risk?
The evidence consistently supports a handful of pillars: regular aerobic and resistance exercise, a dietary pattern rich in whole foods with reduced ultra-processed intake, quality sleep (including screening for obstructive sleep apnea), stress management, smoking cessation, and maintaining a healthy body composition. But the specifics depend on
your cardiometabolic phenotype — someone with insulin resistance and high triglycerides may need a different nutritional strategy than someone with isolated elevated Lp(a). CardioAdvocate's
Phenotype articles cover how lifestyle intersects with specific risk profiles so you can have a more targeted conversation with your doctor.
▶
Where can I find reliable, up-to-date clinical research on cardiovascular health?
CardioAdvocate curates evidence-based cardiometabolic content reviewed by practicing clinicians. Every claim on this site is hyperlinked to its original source — whether that's a PubMed abstract, an ACC/AHA guideline, or a landmark clinical trial. The
CardioAdvocate Library organizes key references by topic, and our
What's Hot page highlights the latest studies making waves in cardiometabolic medicine. For ongoing updates, subscribe to
CardioAdvocate Rounds, our newsletter built for clinicians and informed patients.
▶
Can you recommend resources to help me understand medical terms related to cardiology?
The
CardioAdvocate Glossary was built for exactly this. It defines cardiometabolic terms in plain language — with a conversational tone, real-world analogies, and a "why it matters" explanation for each entry. Think of LDL particles as delivery trucks, HDL as the cleanup crew, and ApoB as the headcount of atherogenic vehicles in your blood. You'll also find glossary terms highlighted throughout every CardioAdvocate article — hover over any teal-dotted term for an instant definition without leaving the page.
▶
Where can I find reliable information on the latest treatments for heart disease?
CardioAdvocate covers the evolving treatment landscape across its
Phenotype and
Insight articles — from SGLT2 inhibitors and GLP-1 receptor agonists to PCSK9 therapies, Lp(a)-lowering agents on the horizon, and the growing conversation around residual inflammatory risk. Each article includes a Deep Dive section with hyperlinked references to clinical trials, guidelines, and expert commentary. Our
What's Hot page tracks breaking studies, and
CardioAdvocate Rounds delivers curated updates on practice-changing developments.
▶
What is a cardiometabolic phenotype and why does it matter?
A cardiometabolic phenotype is a specific pattern of risk factors that cluster together and influence how cardiovascular disease develops in an individual. Not everyone with heart disease has the same underlying drivers — some are driven by lipid burden, others by insulin resistance, inflammation, obesity-related adipokine dysfunction, or genetic factors like elevated Lp(a). Recognizing
your phenotype helps guide more targeted prevention and treatment. CardioAdvocate's entire
Phenotype library is built around this concept, with each article covering a distinct clinical pattern, how it's identified, and what questions to ask your care team.
▶
What should I know about residual cardiovascular risk beyond LDL cholesterol?
Even when LDL-C is at goal, significant cardiovascular risk can persist. This "residual risk" can come from multiple sources: elevated triglyceride-rich lipoproteins, chronic inflammation (including pathways not captured by standard CRP testing), insulin resistance, elevated Lp(a), and adipokine imbalance from visceral adiposity. CardioAdvocate's
Breaking the Loop article explores how these drivers interact in a self-reinforcing cycle, and why addressing only one piece often isn't enough. Understanding residual risk is critical for both patients who "did everything right" and clinicians navigating beyond-statin therapy.
▶
How can I assess my risk for heart disease if I'm under 40?
Traditional risk calculators often underestimate risk in younger adults because they weigh age so heavily. But atherosclerosis starts decades before a heart attack. Key steps include knowing your family history, getting a complete lipid panel (including ApoB and Lp(a)), checking for insulin resistance markers, and discussing coronary artery calcium (CAC) scoring with your doctor if risk factors are present. CardioAdvocate's
Age Is Just a Number article dives deep into why ASCVD risk assessment should start earlier than many think.
▶
What is Lipoprotein(a) and why should I care about it?
Lipoprotein(a), or Lp(a), is a genetically determined lipoprotein that drives cardiovascular risk through both atherogenic and pro-thrombotic mechanisms — and it's not measured on a standard lipid panel. Roughly 20% of people have elevated levels, and most have never been tested. Unlike LDL-C, Lp(a) doesn't respond to diet or statins. CardioAdvocate covers Lp(a) extensively across multiple articles, including its intersection with
aortic stenosis and why it deserves at least one lifetime measurement. New Lp(a)-lowering therapies are on the horizon.
▶
Who are the experts behind CardioAdvocate?
CardioAdvocate was created by a practicing cardiologist with a focus on cardiometabolic prevention. Every article is written, reviewed, and curated with clinical rigor — not aggregated from generic health databases. The site's
Trusted Sources page lists the experts, journals, medical societies, and landmark trials that inform CardioAdvocate's content. To learn more about the mission, visit
Why CardioAdvocate Exists.
Educational Use Disclaimer
Ask the Advocate is intended for medical education only and does not provide medical advice. No physician–patient relationship is formed through use of this tool. Always consult your healthcare professional regarding medical decisions.
If you are experiencing a medical emergency, call 911 or your local emergency number immediately.
Ask better questions. Understand risk earlier. Advocate for your health.
— CardioAdvocate.com
